Shares of Savaria Co. (TSE:SIS – Get Free Report) shot up 4.9% during mid-day trading on Thursday after ATB Cormark Capital Markets raised their price target on the stock from C$30.00 to C$32.00. ATB Cormark Capital Markets currently has an outperform rating on the stock. Savaria traded as high as C$25.62 and last traded at C$25.52. 165,823 shares traded hands during trading, an increase of 6% from the average session volume of 156,380 shares. The stock had previously closed at C$24.32.
Other equities research analysts have also issued reports about the company. Raymond James Financial lifted their price target on Savaria from C$27.00 to C$32.00 and gave the stock an “outperform” rating in a report on Friday. TD Securities raised their price objective on shares of Savaria from C$27.00 to C$31.00 and gave the stock a “buy” rating in a research report on Thursday. Scotiabank lifted their target price on shares of Savaria from C$29.00 to C$30.00 and gave the stock an “outperform” rating in a research note on Friday. Stifel Nicolaus increased their price target on shares of Savaria from C$28.00 to C$29.00 and gave the company a “buy” rating in a research note on Friday. Finally, National Bank Financial raised their price target on shares of Savaria from C$30.00 to C$30.50 and gave the stock an “outperform” rating in a report on Friday. Seven investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat, Savaria has an average rating of “Buy” and a consensus target price of C$30.93.
View Our Latest Analysis on SIS
Key Stories Impacting Savaria
- Positive Sentiment: Multiple brokerages raised price targets and upgraded ratings this morning (ATB Cormark to C$32, Raymond James to C$32, National Bank to C$30.50, Scotiabank to C$30, Desjardins to C$32, Stifel and TD also higher). These raises signal stronger analyst confidence and imply double‑digit upside from current levels. Analyst Rating Roundup
- Positive Sentiment: Savaria reported record 2025 results and stronger margins, with Q4 revenue of C$241.8M and EPS C$0.37 — results the company says position it for a new growth phase around its Savaria One strategy. This fundamental momentum underpins the analyst upgrades. Record 2025 Results
- Positive Sentiment: Coverage pieces note Savaria “entering a new growth phase” after completion of Savaria One and record Q4, reinforcing the narrative for higher future growth and margin improvement. Growth Phase Article
- Neutral Sentiment: The shares briefly hit a 12‑month high following the analyst activity and results, attracting attention from retail and institutional traders. 12‑Month High Coverage
- Neutral Sentiment: Management’s earnings release and conference call are available for review (detailed Q4 release and call transcript), useful for investors who want to assess guidance and cadence of margin improvement. Press Release / Transcript
- Negative Sentiment: Despite the positive newsflow, the stock is lower — likely reflecting short‑term profit‑taking after a run to a 52‑week high, elevated trading volume, and valuation concerns (current reported P/E ~29 and very high PEG). Those factors can pressure the share price even amid upgrades. Market Data / Valuation
Savaria Trading Down 3.4%
The company has a debt-to-equity ratio of 8.27, a current ratio of 1.61 and a quick ratio of 0.91. The business’s 50 day simple moving average is C$24.64 and its 200 day simple moving average is C$22.52. The company has a market capitalization of C$1.83 billion, a price-to-earnings ratio of 29.33, a price-to-earnings-growth ratio of 42.72 and a beta of 1.14.
Savaria (TSE:SIS – Get Free Report) last released its earnings results on Wednesday, March 4th. The company reported C$0.37 EPS for the quarter. Savaria had a net margin of 7.53% and a return on equity of 11.10%. The company had revenue of C$241.78 million during the quarter. Research analysts anticipate that Savaria Co. will post 1.2048518 EPS for the current year.
Savaria Company Profile
Savaria Corporation ( savaria.com ) is a global leader in the accessibility industry. It provides accessibility solutions for the physically challenged to increase their comfort, their mobility and their independence. Its product line is one of the most comprehensive on the market. Savaria designs, manufactures, distributes and installs accessibility equipment, such as stairlifts for straight and curved stairs, vertical and inclined wheelchair lifts and elevators for home and commercial use. It also manufactures and markets a comprehensive selection of pressure management products for the medical market, medical beds for the long-term care market, as well as an extensive line of medical equipment and solutions for the safe handling of patients, including ceiling lifts and slings.
Featured Articles
- Five stocks we like better than Savaria
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- What a Former CIA Agent Knows About the Coming Collapse
- Unlocked: Elon Musk’s Next Big IPO
- Elon Musk already made me a “wealthy man”
Receive News & Ratings for Savaria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Savaria and related companies with MarketBeat.com's FREE daily email newsletter.
